论文部分内容阅读
黄芪为中医传统的上品补气药 ,临床应用非常广泛。为了方便患者 ,开发现代中药新产品 ,山西省中医药研究院提出了研究“注射用黄芪多糖”实现中药静脉用粉针剂的新思路。这一创意得到了有关部门和各级领导的支持 ,1994年获得卫生部的新药临床研究批件。研制者克服了资金、技术
Astragalus membranaceus is a top-grade qi drug in traditional Chinese medicine and has a wide range of clinical applications. In order to facilitate patients, the development of modern new products of traditional Chinese medicine, Shanxi Academy of Traditional Chinese Medicine proposed a study of “injection of astragalus polysaccharide” to achieve a new idea of intravenous injection of traditional Chinese medicine. This idea was supported by relevant departments and leaders at all levels. In 1994, the Department of Health received a new drug clinical research approval. The developer overcomes capital and technology